Ashland vs Chemours
Ashland formulates specialty chemicals for pharmaceuticals, personal care, and coatings, while Chemours produces titanium dioxide and performance chemicals that touch everything from paint to refrigerants. Both have restructured in recent years to shed commodity exposure and improve margins. The Ashland vs Chemours comparison drills into how each company's portfolio shift played out in earnings quality and whether the cleaner business mix justifies current valuations.
Ashland formulates specialty chemicals for pharmaceuticals, personal care, and coatings, while Chemours produces titanium dioxide and performance chemicals that touch everything from paint to refriger...
Investment Analysis
Ashland
ASH
Pros
- Ashland has successfully expanded its adjusted EBITDA margin by 110 basis points to 24.9% despite a sales decline, showing effective cost management and portfolio optimisation.
- The company maintains stable underlying organic volumes in a challenging market, indicating resilience in core demand.
- Ashland's Personal Care segment showed organic sales growth of 5% ex-divestiture in Q4 2025, reflecting strength in end markets.
Considerations
- Ashland reported an 8% decline in Q4 2025 sales to $478 million and a 14% sales decline for full fiscal 2025 to $1.824 billion, impacted by portfolio divestitures.
- Fiscal 2025 recorded a net loss of $845 million due mainly to significant goodwill impairments and sale impacts, raising concerns about asset valuation and profitability.
- Cash flow from operations and free cash flow decreased notably in Q4 2025 compared to prior year, signaling potential liquidity or operational pressures.
Chemours
CC
Pros
- Chemours benefits from a strong portfolio of titanium dioxide and chemical products with global market presence, supporting revenue stability.
- The company has taken steps to reduce debt and strengthen its balance sheet in recent quarters, improving financial flexibility.
- Chemours is exposed to growth in specialty chemicals demand in automotive and electronics sectors, offering growth potential in higher-margin segments.
Considerations
- Chemours faces ongoing cyclicality and commodity price volatility risks due to its exposure to raw materials and global industrial markets.
- Environmental and regulatory compliance costs remain substantial, impacting margins and requiring continuous capital expenditures.
- Recent profit margins have been pressured by rising input costs and competitive pricing dynamics in core product lines.
Related Market Insights
Chemical Sector Shake-Up: Riding Berkshire's Ripple
Berkshire Hathaway's $10B OxyChem bid signals confidence in the chemical sector. Discover investment opportunities & ripple effects. Invest commission-free with Nemo.
Aimee Silverwood | Financial Analyst
October 1, 2025
The Unglamorous Giants: Why Society's Necessary Evils Make Compelling Investments
These companies handle society's dirty work—waste management, hazardous chemicals, and industrial cleanup—creating defensive investment opportunities with inelastic demand and regulatory moats.
Aimee Silverwood | Financial Analyst
July 25, 2025
Related Market Insights
Chemical Sector Shake-Up: Riding Berkshire's Ripple
Berkshire Hathaway's $10B OxyChem bid signals confidence in the chemical sector. Discover investment opportunities & ripple effects. Invest commission-free with Nemo.
Aimee Silverwood | Financial Analyst
October 1, 2025
The Unglamorous Giants: Why Society's Necessary Evils Make Compelling Investments
These companies handle society's dirty work—waste management, hazardous chemicals, and industrial cleanup—creating defensive investment opportunities with inelastic demand and regulatory moats.
Aimee Silverwood | Financial Analyst
July 25, 2025
Which Baskets Do They Appear In?
Chemical Sector: Berkshire's $10B Acquisition Impact
Berkshire Hathaway's potential $10 billion acquisition of Occidental's OxyChem unit signals a major investment in the industrial chemical sector. This move could create ripple effects, presenting opportunities for other chemical manufacturers who stand to gain from shifts in the market.
Published: October 1, 2025
Explore BasketNecessary Evils Portfolio
These companies provide the essential infrastructure and services our society can't function without, even if they're not always popular. Carefully selected by our analysts, these stocks offer defensive stability thanks to their non-negotiable role in the global economy.
Published: June 17, 2025
Explore BasketWhich Baskets Do They Appear In?
Chemical Sector: Berkshire's $10B Acquisition Impact
Berkshire Hathaway's potential $10 billion acquisition of Occidental's OxyChem unit signals a major investment in the industrial chemical sector. This move could create ripple effects, presenting opportunities for other chemical manufacturers who stand to gain from shifts in the market.
Published: October 1, 2025
Explore BasketNecessary Evils Portfolio
These companies provide the essential infrastructure and services our society can't function without, even if they're not always popular. Carefully selected by our analysts, these stocks offer defensive stability thanks to their non-negotiable role in the global economy.
Published: June 17, 2025
Explore BasketBuy ASH or CC in Nemo
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Comparisons
Ashland vs FMC
Ashland specializes in high-performance specialty chemicals serving pharmaceutical excipients, coatings, and personal care markets where formulation expertise commands a meaningful price premium, while FMC focuses on innovative crop protection chemicals that help farmers defend yield against pests and disease across global agricultural markets. Both companies carved out defensible niches within the broader chemicals sector, where pricing power and active R&D pipeline development matter as much as raw volume. Ashland vs FMC walks through margins, end-market exposure, and balance sheet leverage to reveal which specialty chemical play offers better risk-adjusted upside through a demand cycle that's been uneven across their respective markets.
Ashland vs Ingevity
Ashland is a specialty chemicals company divesting commodity exposure and repositioning around high-value additives for pharma, personal care, and coatings, while Ingevity carves out performance chemicals and activated carbon products from pine-based feedstocks. Both businesses are proving that focused specialty chemistry can command pricing power even as broader industrial demand cycles. Ashland vs Ingevity investigates which portfolio transformation has built the more defensible niche and which margin profile sustains itself through the next demand trough.
Ashland vs Ardagh Metal Packaging
Ashland is a specialty chemicals company serving adhesives, coatings, and personal care markets, while Ardagh Metal Packaging manufactures aluminum beverage cans for global beer and soft drink brands. Both serve industrial and consumer end markets where volume stability is relatively high but margin improvement requires constant productivity gains and pricing discipline. Ashland vs Ardagh Metal Packaging investigates operating leverage, free cash flow conversion, and how each company's capital structure and end-market exposure position it to create shareholder value through an economic cycle where input costs and consumer demand can shift quickly.
